Geode Capital Management’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $650K | Buy |
|
|||||
|
2023
Q4 | $547K | Buy |
|
|||||
|
2023
Q3 | $310K | Buy |
|
|||||
|
2023
Q2 | $559K | Sell |
|
|||||
|
2023
Q1 | $2.78M | Buy |
|
|||||
|
2022
Q4 | $2.63M | Buy |
|
|||||
|
2022
Q3 | $5.03M | Buy |
|
|||||
|
2022
Q2 | $5.18M | Buy |
|
|||||
|
2022
Q1 | $4.11M | Buy |
|
|||||
|
2021
Q4 | $6.44M | Buy |
|
|||||
|
2021
Q3 | $7.76M | Buy |
|
|||||
|
2021
Q2 | $5.52M | Sell |
|
|||||
|
2021
Q1 | $7.43M | Buy |
|
|||||
|
2020
Q4 | $1.17M | Buy |
|